However, the lack of association between prostate enlargement and other proinflammatory cytokines suggests that leptin, in this case, serves as an obesity biomarker rather than an inflammation biomarker. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.